NDC 0053-7202

ZEMAIRA

.alpha.1-proteinase Inhibitor Human

ZEMAIRA is a Kit in the Plasma Derivative category. It is labeled and distributed by Csl Behring Llc. The primary component is .

• Product ID: 0053-7202_44e7244d-0e34-4b42-9ae8-a6ddb0352abf
• NDC: 0053-7202
• Product Type: Plasma Derivative
• Proprietary Name: ZEMAIRA
• Generic Name: .alpha.1-proteinase Inhibitor Human
• Dosage Form: Kit
• Marketing Start Date: 2019-04-24
• Marketing Category: BLA / BLA
• Application Number: BLA125078
• Labeler Name: CSL Behring LLC
• Active Ingredient Strength: 0
• NDC Exclude Flag: N
• Listing Certified Through: 2023-12-31

Packaging

NDC 0053-7202-02

1 KIT in 1 CARTON (0053-7202-02) * 76 mL in 1 VIAL, SINGLE-USE (0053-7212-01) * 76 mL in 1 VIAL, SINGLE-USE (0053-7653-80)

• Marketing Start Date: 2019-04-24
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 0053-7202-02 [00053720202]

ZEMAIRA KIT

• Marketing Category: BLA
• Application Number: BLA125078
• Product Type: PLASMA DERIVATIVE
• Marketing Start Date: 2019-04-24

Drug Details

NDC Crossover Matching brand name "ZEMAIRA" or generic name ".alpha.1-proteinase Inhibitor Human"

NDC	Brand Name	Generic Name
0053-7201	Zemaira	alpha-1-proteinase inhibitor human
0053-7202	ZEMAIRA	.ALPHA.1-PROTEINASE INHIBITOR HUMAN
0053-7203	ZEMAIRA	.ALPHA.1-PROTEINASE INHIBITOR HUMAN
0944-2884	GLASSIA	.ALPHA.1-PROTEINASE INHIBITOR HUMAN